PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Novartis to test hydroxychloroquine for coronavirus

Novartis has reached an agreement with US regulators to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalised patients with COVID-19 disease....
Continue Reading →
News

Novartis highlights benefits of Mayzent in MS

New data showing the benefits of Novartis' Mayzent (siponimod) in patients with secondary progressive multiple sclerosis (SPMS) have been published in the April supp...
Continue Reading →
News

Bayer partners with Population Health Research Institute on COVID-19 research

As of this morning – Wednesday April 22 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 129,044 with 17,337 deaths. Bayer's Canadian...
Continue Reading →
News

Ritedose selects ChargePoint Technology’s transfer solution for biomanufacturing project

The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with Char...
Continue Reading →
News

Lilly partners with NIH to test Olumiant in patients hospitalized with COVID-19

Drug companies worldwide are testing existing medicines as potential treatments for COVID-19—plus working on new therapeutics—with few answers yet. Now, Eli Lilly is...
Continue Reading →
News

Pharma AstraZeneca, Merck finally grab a green light for rare-disease med Koselugo

It’s been a long road for AstraZeneca’s selumitinib, but one that’s finally led to a green light for the British drugmaker and its partner, Merck. The FDA approved...
Continue Reading →
News

Dec Group announces the acquisition of Inno4Life

Ecublens, Switzerland: April 9, 2020 Dec Group has announced the acquisition of Inno4Life based in Breda, The Netherlands, allowing offering comprehensive solution...
Continue Reading →
News

AstraZeneca to test blood cancer drug Calquence in COVID-19 after NIH sees ‘some clinical benefit’

Add another drugmaker to the list of those repurposing existing meds for COVID-19. AstraZeneca is now trying to turn a blood cancer drug against dangerous immune com...
Continue Reading →
News

BIOQUELL’S RAPID BIO-DECONTAMINATION SERVICE (RBDS) IS EFFECTIVE AGAINST CORONAVIRUS

Fully inclusive and managed RBDS uses Bioquell’s 35% hydrogen peroxide vapour solution to eliminate pathogens, providing a 6-log sporicidal kill With the number of...
Continue Reading →
News

GSK links with Vir Biotechnology to find coronavirus solutions

As of this morning – Tuesday April 7 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 51,608 with 5,373 deaths. GlaxoSmithKline has bou...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026